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Abstract
Genes that underlie human disease are important subjects of systems biology research. In the present study, we demonstrate
that Mendelian and complex disease genes have distinct and consistent protein–protein interaction (PPI) properties. We show
that ﬁve different network properties can be reduced to two independent metrics when applied to the human PPI network.
These two metrics largely coincide with the degree (number of connections) and the clustering coefﬁcient (the number of
connections among the neighbors of a particular protein). We demonstrate that disease genes have simultaneously unusually
high degree and unusually low clustering coefﬁcient. Such genes can be described as brokers in that they connect many
proteins that would not be connected otherwise. We show that these results are robust to the effect of gene age and
inspection bias variation. Notably, genes identiﬁed in genome-wide association study (GWAS) have network patterns that are
almost indistinguishable from the network patterns of nondisease genes and signiﬁcantly different from the network
patterns of complex disease genes identiﬁed through non-GWAS means. This suggests either that GWAS focused on
a distinct set of diseases associated with an unusual set of genes or that mapping of GWAS-identiﬁed single nucleotide
polymorphisms onto the causally affected neighboring genes is error prone.
Key words: protein–protein interaction network, disease genes, evolutionary age.
Introduction
Protein interaction data are commonly drawn as networks
with nodes representing proteins and edges representing
the detected protein interactions. Individual proteins (or no-
des) can then be characterized with a variety of topological
measures, such as degree, betweenness centrality, and clus-
tering coefﬁcient. Thesemeasuresturn outto relate to func-
tional properties of genes such as, for example, the closer
the two proteins are located to each other in protein–
protein networks the more similar they are in functional
annotations (Sharan et al. 2007). Network properties also
appear to be somewhat predictive of protein function with,
for instance, highly connected and globally centered genes
in protein networks tending to be physiologically more
‘‘important’’ and less dispensable (Jeong et al. 2001; Hahn
and Kern 2005; Wuchty and Almaas 2005).
Network properties of genes underlying human inherited
diseases have been investigated (Goh et al. 2007; Feldman
et al. 2008; Jiang et al. 2008). Although different studies
focused on substantially different disease gene sets, they
reached some similar conclusions. Speciﬁcally, they found
that disease genes encode non-hub proteins and tend to
have an intermediate levels of degree in the protein–protein
interaction (PPI) networks (Goh et al. 2007; Feldman et al.
2008). This allowed network properties of disease genes to
be used for the purpose of disease gene prioritization (e.g.,
Kohler et al. 2008; Wu et al. 2008).
The current understanding of network properties of dis-
ease genes is limited for a number of reasons. The ﬁrst prob-
lem is that the widely used network property measures are
strongly correlated with each other, which makes it difﬁcult
to relate different studies using different measures to each
other.ThesecondproblemisthatmanystudiespooledMen-
delian and complex disease genes, as well as complex dis-
ease genes detected in pedigree- or candidate gene–based
studies with those detected in genome-wide association
studies (GWASs). Third,previous studies have not taken into
account the fact that Mendelian disease genes tend to be
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GBEevolutionarily old and complex disease genes tend to be of
an intermediate age (Domazet-Loso and Tautz 2008; Cai
et al. 2009). Given that several network properties are cor-
related with gene age, such as, for example, older genes
tendingtohavemoreprotein–proteinconnections,wethink
this feature of disease genes must be considered. Finally, it is
possible that disease genes have been better studied than
other genes and thus might have artifactually high numbers
of discovered PPIs.
In the present study, we use high-quality data sets of
human disease genes in conjunction with a comprehensive
human PPI network and a validated measure of evolutionary
age to investigate the relationships among ﬁve network to-
pology metrics. We deﬁne two principal components (PCs)
that capture most of the network properties and address
several key questions concerning disease genes, including:
1) Are disease genes exceptionally well connected and glob-
allycentered inthe proteinnetwork? 2)Canweidentifychar-
acteristic network properties that distinguish disease from
nondisease genes? 3) Are properties of disease genes more
homogeneous than those of randomly sampled genes? and
4) To what extent do genes identiﬁed in GWAS exhibit
network properties similar to those of other disease genes?
Materials and Methods
Integrated PPI Network
We obtained the integrated human PPI network (between
10,299 human proteins) from Bossi and Lehner (2009). The
network contains 80,922 interactions compiled from a total
of21differenthumanPPIdatabases(seetable1ofBossiand
Lehner 2009 for details). All interactions included are sup-
ported by at least one piece of direct experimental evidence
demonstrating physical interaction between two human
proteins (Bossi and Lehner 2009). Several network metrics
we computed (see below) requirea connected graph; there-
fore, we extracted the largest connected component (in-
cluding 10,042 genes and 80,543 connections), and all
data analyses were conducted with this connected compo-
nent (supplementary ﬁg. S1, Supplementary Material
online).
Network Centrality and Topological Measures
The interaction network was represented as an undirected
graph with proteins as nodes and interactions as undi-
rected edges. We considered ﬁve measures to capture
the distinct features of network centrality and topology
of each node:
1. Degree centrality (k) of a given node is simply the
number of links that a node has with other nodes in
the network (Nieminen 1974; Dorogovtsev and
Mendes 2003).
2. Betweenness centrality (C
Btw) is the fraction of
shortest paths passing through node i:
CBtw
i 5
X N
j 51
X j  1
k51
gjkðiÞ
gjk
;
where gjk(i) is the number of shortest paths from j to k
through i and gjk is the total number of shortest paths
between j and k. C
Btw measures the global importance
of a protein in communicating between pairs of proteins
from the viewpoint of shortest paths (Freeman 1977).
3. Current information ﬂow (C
Cif) is computed using
a method modeling a PPI network as an electrical
circuit, where interactions are modeled as resistors
and proteins as interconnecting junctions (Missiuro
et al. 2009). Computation of C
Cif takes into account
the relative contribution of all possible paths. Proteins
central to the transmission of biological information
throughout the network have higher C
Cif. It has been
shown that C
Cif provides more consistent results than
C
Btw when noisy data is added to a PPI network
(Missiuro et al. 2009).
4. Bridging centrality (C
Bdg) measures the extent to
which a node or an edge is located between
well-connected regions (Hwang et al. 2006). It is
deﬁned as
C
Bdg
i 5CBtw
i   BCi;
where CBtw
i is the betweenness centrality of node i, and
BCi is the bridging coefﬁcient that assesses the local
bridging characteristics in the neighborhood of node i,
which is deﬁned as
Table 1
Mean and Variance of Network Measures of Genes
k Btw Cif Bdg Clu
Nondisease 0.743 (0.363) 3.66 (1.100) 4.33 (0.243)  5.02 (0.369) 0.34 (0.099)
Mendelian 0.772
ns (0.272
#) 3.91
** (0.924
ns) 4.45
** (0.214
ns)  4.94
ns (0.240
##) 0.23
*** (0.068
#)
Complex 0.828
* (0.273
#) 3.94
*** (0.984
ns) 4.49
*** (0.234
ns)  4.93
* (0.230
###) 0.19
*** (0.049
##)
GWAS 0.669
ns (0.328
ns) 3.66
ns (1.140
ns) 4.37
ns (0.229
ns)  5.04
ns (0.291
ns) 0.27
ns (0.084
ns)
The network measures include degree centrality (k), betweenness centrality (Btw), current information ﬂow (Cif), bridging centrality (Bdg), and clustering coefﬁcient
(Clu). All measures, except of Clu, were log10-transformed before computation of mean and variance (inside parentheses). Student’s t-tests were conducted to compare the
mean between disease and nondisease genes (signiﬁcance levels:
nsnot signiﬁcant;
*P , 1   10
 3;
**P , 1   10
 5;
***P , 1   10
 10). F-tests were conducted to compare the
variance between disease and nondisease genes (signiﬁcance levels:
nsnot signiﬁcant;
#P , 1   10
 5;
##P , 1   10
 10). Note that Mann–Whitney U test and Levene’s test, which
are less sensitive to nonnormal distributions, were also used to test equality of means and variances, respectively; similar results were produced (data not shown).
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where d(i) is the degree of node i and N(i) is the set of
neighbors of node i. C
Bdg can help to identify bridging
nodes, that is, nodes with high information ﬂow that are
located between highly connected modules.
5. Clustering coefﬁcient (C
Clu) is deﬁned as
CClu
i 5
2n
kiðki   1Þ
;
where n denotes the number of direct links connecting
the Ki nearest neighbors of node i. C
Clu ranges from zero
(for a node that is part of a loosely connected group) to
one (for a node at the center of a fully connected cluster).
C
Clu measures the degree of interconnectivity in the
neighborhood of a node (Watts and Strogatz 1998).
A Matlab toolbox called SBEToolbox (Systems Biology
and Evolution Toolbox, http://www.bioinformatics.org/
sbetoolbox/) was developed to calculate all these
network metrics.
Human Disease Genes
First, we obtained 952 Mendelian disease genes from the
nonredundant version of the Mendelian Inheritance in
Man (OMIM) called hOMIM (Blekhman et al. 2008), which
is hand-curated and free of complex phenotypic entries.
We mapped about 68% (647) of them onto the network.
Second, we retrieved 1,656 complex disease genes from
genetic association database (GAD) (Becker et al. 2004).
We excluded genes that are also Mendelian disease genes
from the GAD gene set. We mapped 67% (1,110) of them
onto the network. Third, we obtained GWAS genes (i.e.,
genes reported in GWA studies) from the online catalog of
published genome-wide association studies (http://www.
genome.gov/gwastudies; Hindorff et al. 2009). As of date
of access (18 October 2009), the catalog contained 1,293
GWAS genes associated with 269 distinct traits reported in
419 publications. We removed 592 GWAS genes associated
with nondisease traits (such as, height, weight, skin pigmen-
tation, and ‘‘select biomarker’’). We mapped 59% (412) of
the remaining 701 genes onto the network. Finally, we used
the comprehensive collection of 21,528 human protein-
coding genes from the Ensembl build 50 (Flicek et al.
2008) as a representative set of all well-characterized human
genes. Genes that do not appear in any of the three disease
gene sets are regarded as nondisease genes.
Evolutionary Age of Genes
Domazet-Loso and Tautz (2008) studied the evolutionary or-
igin of human protein-coding genes using a well-supported
phylogenyof19speciesthatwerecarefullychosenbasedon
the availability of complete annotated genomes, the reliabil-
ity of phylogenetic relationships, andthe importanceofevo-
lutionary transitions (supplementary ﬁg. S2, Supplementary
Material online). The internodes at different phylogenetic
levels form a phylostratigraphic scheme of metazoan evolu-
tion (Domazet-Loso et al. 2007). To place all human genes
into these phylostrata, they used Blast analysis with an E
value cutoff of 0.001 to compare human proteins against
the National Center for Biotechnology Information nonre-
dundant database. They then mapped human genes ac-
cording to the evolutionary origin of their founder genes
on the phylogeny.
Adopting the Dollo parsimony principle (i.e., assuming
that genes can be lost but cannot reevolve independently
indifferentlineages[LeQuesne1974;Farris1977]orbehor-
izontally transferred), we used the phylostratum of each
gene to approximate its evolutionary age (reversing the or-
der of the various phylostrata to obtain an estimate of the
gene age). Genes at the highest phylostratum (19) were as-
signed into the youngest age group 1, the lowest phylostra-
tum1wereassignedintotheoldestagegroup19,andsoon
andsoforth.Toincreasestatistical power,wefurther pooled
the genes in the 19 age groups into six combined age clas-
ses: Mammalia/Primates, Chordata/Vertebrate, Eumetazoa/
Deuterostomia, Metazoan, Eukaryota, and cellular organ-
isms (see supplementary ﬁg. S2, Supplementary Material
online for the pooling schema and the numbers of genes
in six age groups after combination). The nonsynonymous
substitution rate (dN) and synonymous substitution rate
(dS) for human–Macaque orthologs were downloaded from
BioMart (http://www.biomart.org).
Results
Weusedanintegratednetworkdatasetthatcontainsnearly
half of all human proteins (Bossi and Lehner 2009). The
Mendelian and complex disease genes were retrieved from
hOMIM (Blekhman et al. 2008) and GAD (Becker et al.
2004), respectively. These two types of disease genes were
investigated separately because they show distinct proper-
ties in many respects (Blekhman et al. 2008; Cai et al. 2009).
In addition, we obtained genes identiﬁed in GWAS of hu-
man disease (Hindorff et al. 2009). In total, 647 hOMIM,
1,110 GAD, and 412 GWAS genes can be mapped on
the PPI network (Materials and Methods). However, the
three sets are not mutually exclusive. For instance, 331
genes are shared between hOMIM and GAD, whereas
109 genes are shared between GAD and GWAS (supple-
mentary ﬁg. S3, Supplementary Material online). In order
to study each type of disease genes independently, we re-
movedhOMIMgenesfromGADgenesetandremovedboth
hOMIM and GAD genes from GWAS gene set. No genes
were removed from hOMIM as all of them were manually
Network Properties of Human Disease Genes GBE
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types (Blekhman et al. 2008). The results reported in this pa-
per were based on data analysis with three nonoverlapping
sets of 647 Mendelian disease genes, 779 complex disease
genes, and 287 GWAS genes.
Characteristic Network Properties of Mendelian
and Complex Disease Genes
Wecalculateddegree(k),betweennesscentrality(C
Btw),cur-
rent information ﬂow (C
Cif), bridging centrality (C
Bdg), and
clustering coefﬁcient (C
Clu) for each applicable protein in
the complete interaction network (Materials and Methods).
Table 1 provides the results of comparisons of the mean and
variance of these metrics between disease genes and non-
disease genes. Average degree (k) of Mendelian disease
genes is not different from that of nondisease genes, and
 k of complex disease genes is only marginally signiﬁcantly
higher than that of nondisease genes. This result suggests
that Mendelian and complex disease genes are not hub
genes, which is consistent with results of previous studies
(Goh et al. 2007; Feldman et al. 2008). Mendelian and com-
plex disease genes have signiﬁcantly higher C
Btw and C
Cif,
suggestingthatthesediseasegenestendtooccupynetwork
positions that are of global importance in communications
between protein pairs. At the same time, they have signif-
icantly lower C
Clu suggesting that the number of connec-
tions among the neighboring proteins of disease genes is
unusually low. Interestingly, the variance of k, C
Bdg, and C
Clu
of Mendelian and complex disease genes is also unusually
small, suggesting consistency in network properties of dis-
ease genes. Finally, GWAS genes do not show any statisti-
cally signiﬁcant differences from nondisease genes. Note
that this might be partially due to the small sample size
of GWAS genes. We will return to this question later in
the paper.
It seems that Mendelian and complex disease genes (but
not GWAS genes) have distinct and consistent network
properties;however,thisisdifﬁculttointerpretforthreerea-
sons. First, the network metrics are strongly correlated with
each other (table 2) and thus it is not entirely clear which
network properties tend to be truly distinct for disease
genes. Second, evolutionary ages of Mendelian and com-
plex disease genes differ from those of nondisease genes
(Domazet-Loso and Tautz 2008; Cai et al. 2009) and genes
of different ages tend to have different network properties
(see below). Thus, disease genes might have distinct net-
work properties simply due to their different age. Finally,
it is possible that disease genes have been studied more
thoroughlycomparedwithothergenesandthusmighthave
a disproportionately high number of detected PPIs. Below
we 1) reduce the dimensionality of the network metrics us-
ing principal component analysis (PCA), 2) show that the
network properties of disease genes are distinct over and
above what is expected of genes of their age, and 3) provide
evidence that the inspection bias cannot account for the ob-
served results.
Deﬁning Two Key PCs for Network Properties of
Disease Genes
To understand the relationships among the ﬁve network
measures, we conducted PCA. All variables that show de-
viation from normality (i.e., all except C
Clu) were log trans-
formed and then scaled to zeromean and unit variance. The
result of PCA shows that the ﬁrst two PCs explain 73.4% of
the total variation (40.7% and 32.7% for the ﬁrst and sec-
ond PC, respectively).
The magnitudeandsignofeachvariable’s contributionto
the ﬁrst two PCs are shown in a PC biplot (ﬁg. 1A). Each
variable is represented by a line from the origin to a point
with coordinates (c1, c2). The coordinates c1 and c2 are
the correlations between the variable and the ﬁrst and sec-
ond axis, respectively. Longer lines indicate stronger corre-
lations between a PC (biplot axis and everything related to
that) and the corresponding variable. The ﬁrst PC (PC 1) cor-
relates most strongly with three variables, k, C
Btw, and C
Cif;
the second PC (PC 2) correlates strongly with the other two
variables, C
Bdg and C
Clu.
PCA was conducted with all (disease and nondisease)
genes. Nondisease and disease genes were highlighted sep-
aratelyin heat mapstoshow theirdensityand distributionin
the PC 1–2 space (ﬁg. 1B,C,D,E). Compared with nondi-
sease genes, Mendelian, and complex disease genes occupy
a much narrower region. Distributions of Mendelian and
complex disease genes are more biased (41%, 27%,
20%, and 12% in I–IV quadrants for Mendelian disease
genes, ﬁg. 1C; 49%, 26%, 18%, and 7% for complex dis-
ease genes, ﬁg. 1D) than nondisease genes, which are more
evenly distributed in the four quadrants (29%, 23%, 29%,
Table 2
Correlation Coefﬁcients between Variables: Degree (k), Between-
ness Centrality (Btw), Current Information ﬂow (Cif), Bridging
Centrality (Bdg), Clustering Coefﬁcient (Clu), Nonsynonymous
Substitution Rate (dN), Synonymous Substitution Rate (dS), the
Nonsynonymous-to-Synonymous Substitution Ratio (dN/dS), and
Evolutionary age (age)
k Btw Cif Bdg Clu dN dS
Btw 0.846
Cif 0.947 0.945
Bdg 0.383 0.660 0.507
Clu 0.625 0.334 0.480 0.043
dN 20.144 20.122 20.133 20.033 20.082
dS 20.060  0.031 20.039 0.008 20.054 0.505
dN/dS 20.140 20.128 20.137 20.043 20.065 0.890 0.124
Signiﬁcant coefﬁcients (P , 0.001, Spearman correlation test) are indicated in
bold.
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toward the ﬁrst quadrant with proportionally more Mende-
lian and complex disease genes having positive PC 1 and PC
2( G-test, P , 0.001 for the comparison of Mendelian and
complex disease genes with nondisease genes). Note that
complex disease genes have a more biased distribution to-
ward the ﬁrst quadrant than the Mendelian genes (G-test, P
, 0.001). Because PC 1 correlates strongly and positively
with degree (k) and PC 2 correlates strongly and negatively
with clustering (C
Clu), the above results can be stated differ-
ently: Mendelian orcomplex disease genes tend tobe highly
connected (high k) to genes that are themselves are not very
well connected (low clustering C
Clu). This property can be
thought of as ‘‘brokering’’ value of a proteinsuch that a pro-
tein with a high brokering value connects many other pro-
teins that would not be connected otherwise. For an
example of the connection patterns for two broker genes
(SUMO4 and PRKCZ) and two examples of nonbroker genes
with similar values of k (PCBP1 and BMS1), see supplemen-
tary fig. S4 (Supplementary Material online).
Distribution of GWAS genes in the four quadrants is less
biased (37%, 24%, 27%, and 12%, ﬁg. 1E) than that of
other disease genes and is only marginally enriched in the
direction of the ﬁrst quadrant (P 5 0.016) compared with
nondisease genes. Their distribution is also not different
from that of Mendelian genes (P 5 0.32), however, it is sig-
niﬁcantly different from that of complex disease genes (P ,
0.01).Thisindicatesthatthedifferentnetworkpropertiedof
GWAS genes compared with complex disease genes is not
merely aresultofthe small numberof GWASgenes andlack
of power.
We further placed disease and nondisease genes on the
scatter plot of k and C
Clu (ﬁg. 2). It is clear that most of the
highly connected Mendelian (ﬁg. 2A) and complex (ﬁg. 2B)
disease genes (with log10(k)   1.5) have a low C
Clu ( 0.2),
which is not the case for the nondisease genes with similar
values of k. GWAS genes do not show this distinct feature
(ﬁg. 2C). We split the scatter plot area ad hoc (based on vi-
sual inspection) into three regions deﬁned by log10(k) 5 1.5
(or k 5 31) and C
Clu 5 0.2 (ﬁg. 2). Region I contains genes
with relatively low k, whereas regions II and III contain genes
with high k. The difference between regions II and III is that
region III contains genes with lower C
Clu. Region III repre-
sents a characteristic ‘‘high brokering value’’ zone, in which
FIG.1 . —PCA of network properties of human genes. (A) Biplot
showing ﬁve variables (represented by arrows): degree (k), betweenness
centrality (Btw), current information ﬂow (Cif), bridging centrality (Bdg),
and clustering coefﬁcient (Clu). (B,C,D,E) Heat maps show density and
distribution of nondisease, Mendelian, complex, and GWAS genes, on
the PC space. Numbers at the four corners of each heat map is the
percentages of genes located inside the corresponding quadrants.
The dished line indicates 90% conﬁdence ellipse for the probability that
the corresponding genes will fall within the area.
Network Properties of Human Disease Genes GBE
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much more often. For instance, only 2.4% and 1.3% of
all genes in region II are Mendelian and complex genes,
while this number goes up to 10.4% and 16.6% in region
III,respectively(P,0.001forallcomparisons,G-test).Again
the pattern is much less pronounced albeit marginally sig-
niﬁcant for GWAS genes (III [3.7%] vs. II [1.3%],
P 5 0.008, G-test).
Network Properties as a Function of Gene Age
To investigate whether genes of different ages tend to have
different network properties and whether this can explain
differences in network properties of disease genes, we
grouped all genes into different age groups. Gene age
was estimated based on the concept of phylostrata
(Domazet-Loso and Tautz 2008), assuming Dollo parsimony
(Le Quesne 1974; Farris 1977). Six age groups were deﬁned
(labeled 1–6, where group 1 includes the youngest genes
and group 6 the oldest genes) and each protein was as-
signed to one of these age groups (Materials and Methods).
Disease and nondisease genes are not distributed equally in
different age groups. Mendelian disease genes are overrep-
resented in the old group, whereas complex disease genes
are overrepresented in the middle age groups (Domazet-
Loso and Tautz 2008; Cai et al. 2009).
Figure3 illustrates thechanges ofPCs asa functionof the
evolutionary age of the gene. For nondisease genes, aver-
age PC 1 increases monotonically with gene age (Spear-
man’s q 5 0.104, P 5 4.44   10
 16), indicating that
older nondisease genes have higher levels of k, C
Btw, and
C
Cif. This is not unexpected because proteins of older genes
hadmoretimetoacquireinteractionswith otherproteins.In
contrast, Mendelian and GWAS genes show no correlation
between PC 1 and evolutionary age (both P . 0.001). For
complex disease genes, the correlation is positive and mar-
ginally signiﬁcant (Spearman’s q 5 0.113, P 5 5.61   10
 4,
table 3; ﬁg. 3A). All disease genes have relatively high level
of PC 1 compared with nondisease genes of the same age
(ﬁg. 3A). PC 2 shows no correlation with gene age for all the
genes (table 3, ﬁg. 3B). We also show the changes of indi-
vidual network metrics as a function of gene age in the sup-
plementary Information (supplementary fig. S5–S7,
Supplementary Material online).
FIG.2 . —Characteristic changes of clustering coefﬁcient (Clu) as
a function of degree (k) for disease genes. Red crosses are data points of
disease genes, (A) Mendelian, (B) complex, and (C) GWAS. Red circles
are means of Clu for data points in the bins with unequal widths (so that
each bin contains same number of disease genes). Blue crosses and blue
squares are for nondisease genes for comparison. The solid line shows
the quadratic ﬁt of a linear model with ﬁrst-order and second-order
predictors of log10(k). The red and blue lines are for disease and
nondisease genes, respectively. Rectangles represent three empirically
deﬁned regions (I, II, and III). Percentages of genes that are disease
genes in each region are given in parentheses. The results of v
2 tests for
the percentage of region III against those of regions I and II are III versus
II, P 5 7.4   10
 9 and III versus I, P 5 0.02 for Mendelian disease genes;
III versus II, P 5 0 and III versus I, P 5 8.9   10
 9 for complex disease
genes; III versus II, P 5 0.008 and III versus I, P 5 0.8 for GWAS genes.
Cai et al. GBE
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of the characteristic patterns for all three types of disease
genes. Given that the numbers of disease genes (especially
those in the young age groups) are small, it is possible that
thelackofcorrelationbetweenPC1andgeneageindisease
genes is a product of the small sample size. To rule out this
possibility, we randomly sampled nondisease genes in each
age bin such that the number of genes in the sampled sub-
set was equal to the number of Mendelian, complex, or
GWAS genes in the corresponding age bin, respectively.
We repeated this subsampling process to create 10,000 rep-
licates of nondisease gene sets and computed the Spear-
man’s correlation coefﬁcients between PC 1 and the age
of the gene for these subsets. The observed correlation co-
efﬁcients obtained for disease genes falls at the very end of
the lower tail of the resampled q distribution (empirical P ,
0.0001, 6.67   10
 4, and 3.33   10
 4 for Mendelian, com-
plex, and GWAS genes, respectively). Thus, the lack of cor-
relation betweenPC 1 and gene age cannot be attributed to
the small sample size of disease gene sets.
FIG.3 . —PCs as a function of gene age. (A) PC 1, nondisease versus disease genes; (B) PC 2, nondisease versus disease genes. Types of disease
genes include Mendelian, complex, and GWAS genes, at left, middle, and right panels, respectively. Box plots of PCs for nondisease genes (shaded blue)
and disease genes (shaded red) are superimposed by average PCs for nondisease genes (blue circles) and disease genes (red squares). Regression lines
are depicted for nondisease genes (blue) and disease genes (red).
Table 3
Correlations between Evolutionary Age of Genes (age) and Variable x: the First PC (PC 1), Degree (k), Betweenness Centrality (Btw), Current
Information Flow (Cif), the Second PC (PC 2), Bridging Centrality (Bdg), and Clustering Coefﬁcient (Clu)
corr (age, x) All Nondisease Mendelian Complex GWAS
PC 1 0.093 (5.55 3 10
216) 0.104 (4.44 3 10
216) 0.038 (0.380) 0.129 (8.64 3 10
24)  0.014 (0.774)
k 0.090 (0) 0.105 (0)  0.015 (0.706) 0.117 (0.001)  0.007 (0.870)
Btw 0.083 (1.11 3 10
216) 0.104 (0)  0.021 (0.601) 0.052 (0.150) 0.012 (0.775)
Cif 0.079 (2.33 3 10
215) 0.099 (0)  0.016 (0.692) 0.065 (0.070) 0.003 (0.951)
PC 2  0.022 (0.057)  0.025 (0.051) 0.059 (0.176)  0.046 (0.238)  0.006 (0.898)
Bdg 0.016 (0.109) 0.033 (0.003)  0.027 (0.499)  0.094 (0.009)  0.004 (0.929)
Clu 0.015 (0.132) 0.030 (0.007)  0.057 (0.144)  0.045 (0.208)  0.045 (0.273)
Signiﬁcant coefﬁcients (P , 0.001, Spearman correlation test) are indicated in bold.
Network Properties of Human Disease Genes GBE
Genome Biol. Evol. 2:815–825. doi:10.1093/gbe/evq064 Advance Access publication October 11, 2010 821Because Mendelian and complex disease genes have dis-
tinct age distributions (Domazet-Loso and Tautz 2008; Cai
et al. 2009, supplementary ﬁg. S8, Supplementary Material
online), it is possible that their distinct network properties
are simply a function of their age. To rule out this possibility,
we randomly sampled a subset of nondisease genes to the
same size and age distribution of corresponding diseases
genes (ﬁg. 4). The procedure allowed us to control for dif-
ferent size and age distribution of gene groups. Figure 4A,B
shows the results derived from using Mendelian and com-
plex disease genes as subsampling targets, respectively.
Means and variances of PC 1 and PC 2 for subsampled gene
subsets are shown as scatter crosses. The subsampling pro-
cedure was repeated 10,000 times to get the 99.9% con-
ﬁdence ellipses. Observed data points for nondisease genes
are within the conﬁdence ellipses. The variance of PC 1 for
Mendelian disease genes is lower, and the mean of PC 1 for
complex disease genes is higher than expected by chance.
Mendelian and complex disease genes have signiﬁcantly
higher mean and lower variance of PC 2. As expected based
on the above results, the GWAS genes do not deviate
signiﬁcantly from the subsampled nondisease genes
(ﬁg. 4). Note that the GWAS genes have the same age
distribution as the nondisease genes (supplementary ﬁg. S4,
Supplementary Material online) and thus ﬁgure 4 shows
comparison of the GWAS genes with nondisease genes
without any subsampling.
Impact of the Inspection Bias
Last,weaddresstheproblemofinspectionbias—theimpact
of more intense investigation of known, especially disease
genes on the number of detected PPIs. The inspection bias
alone should not dramatically affect the signals we have de-
tected because Mendelian and complex disease genes do
not have a higher average degree than nondisease genes
(table 1), which is opposite to the expectation of inspection
bias. Nevertheless, we conducted additional tests to control
for other less obvious potential effects of this bias.
First, we applied a simple assay to show that disease
genes have indeed been studied more intensively than
other genes. We separated human genes into named
and unnamed genes according to whether they have
HGNC-(HUGO Gene Nomenclature Committee)-approved
names. Genes under intensive experimental studies tend
FIG.4 . —Variance and mean of PCs of disease genes. The open circle and square indicate observed data points of variance against mean of the
two PCs for Mendelian and complex disease genes, respectively. The crosses are data points of mean and variance for 10,000 randomly sampled subsets
of nondisease genes, with the same size and age distribution as (A) Mendelian and (B) complex disease genes. The contour denotes the 99.9%
conﬁdence ellipse.
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undergone fewer studies may not have such names. In
our gene set, there are 447 unnamed genes, including
419 nondisease genes, 6 Mendelian disease genes, 19
complex disease genes, and 3 GWAS genes (supplemen-
tary table S1, Supplementary Material online). Proportion-
ally disease genes are more likely to be named than
nondiseasegenes(P ,0.0003forallthreetypesofdisease
genes, G-test).
We then ﬁltered out all unnamed genes and repeated
data analysis with only named genes. In this way, we de-
creased the impact of inspection bias due to nondisease
genes being disproportionately poorly studied. We found
that all results in above sections hold without any qualitative
changes (data not shown). Second, we randomly sampled
nondisease genes to generate multiple gene sets with the
samenumberofgenesandthesamedistributionofkasthat
in the corresponding disease gene set. For each type of dis-
ease genes, we constructed 10,000 such replicates and ob-
tained the distribution of C
Btw, C
Cif, C
Bdg, and C
Clu.W e
found that, except for C
Bdg, the three other network meas-
ures for Mendelian and complex disease genes fall far away
from the center of distribution of the measures, with signif-
icantly higher C
Btw and C
Cif and signiﬁcantly lower C
Clu
(ﬁg. 5). Thus controlling for k does not affect the detection
of characteristic network properties of disease genes. This
conﬁrms that genes with the same level of k still differ in
other aspects depending on whether they are disease genes
or not.
Discussion
Given the functional importance of PPI networks, network
properties of genes underlying human diseases might reveal
important clues about the origin and etiology of disease. It is
not surprising that these properties have been a subject of
many studies (Goh et al. 2007; Feldman et al. 2008; Jiang
et al. 2008). Here, we have tried to improve upon these
studies in a number of ways. First, we used well-curated
nonredundant disease gene sets separated into three cate-
gories:Mendeliandiseasegenes,complexdiseasegenesdis-
covered in pedigree studies, and genes discovered through
GWAS. Second, we considered correlations among various
network metrics and reduced them to two independent PCs
using PCA. Third, we incorporated into our analysis the evo-
lutionary age of genes, which has not been controlled for by
thestudiesofnetworkpropertiesofdiseasegenesandrarely
in the studies of protein–protein networks in general (with
some notable exceptions, e.g., Kunin et al. 2004; Wuchty
and Almaas 2005; Kim et al. 2007). PPI networks are not
static in evolution. Rather they change constantly through
the rewiring of interactions as well as through the gain
andloss ofgenes. Older genes are likely todifferin the num-
ber and type of PPIs and we know that disease genes do
have biased age distributions (Domazet-Loso and Tautz
2008; Cai et al. 2009). We therefore believe that incorpo-
rating information about the evolutionary age of each
gene into the network analysis is essential for revealing
characteristic network properties of genes. Finally, we
tested whether our results could be explained by the arti-
fact of the inspection bias: the increase in the number of
PPIs produced through more careful studies of well-known
genes.
We demonstrated that ﬁve network metrics (degree, be-
tweenness centrality, information ﬂow, bridging centrality,
and clustering coefﬁcient) can be mapped onto two PCs
without losing much ability to explain the overall variation
in the data. The ﬁrst PC correlates strongly with degree, be-
tweennesscentrality,andcurrentinformationﬂow,whereas
the second PC correlates strongly and positively with
FIG.5 . —Distributions of network metrics for subsampled non-
disease genes. Network metrics include betweenness centrality (Btw),
current information ﬂow (Cif), bridging centrality (Bdg), and clustering
coefﬁcient (Clu). Values of network metrics for (A) Mendelian and (B)
complex disease genes are shown as vertical red bars. For each
distribution, 10,000 replicates of nondisease genes with same number
and degree of genes as disease genes were constructed.
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tering coefﬁcient. We discovered that Mendelian and com-
plex disease genes have unusually high values of both PC 1
and PC 2. In other words, disease genes tend to be highly
connected (large values of PC 1 and thus degree) but often
they are connected to genes that are not connected well
among themselves (high values of PC 2 and thus low values
of clustering). In this way, disease genes appear to serve as
‘‘brokers.’’ Just as human brokers connect strangers who
otherwise would not know each other, broker proteins con-
nect ‘‘stranger’’ proteins that do not interact with each
other. It is possible that in this way, disease genes ﬁnd them-
selvesinparticularlyfragilepositionsinPPInetworksandthis
is why their disruption leads to identiﬁable disease pheno-
types.
The network properties of Mendelian and complex dis-
ease genes appear both distinct and remarkably consistent.
Indeed, the value of degree for disease genes does not only
have an elevated mean value but it also has very low vari-
ance.Similarly, boththe mean and the varianceof clustering
coefﬁcient for disease genes are signiﬁcantly reduced com-
pared with those of nondisease genes. This consistency can
be seen also in that the network properties of disease genes
do not vary with age. This is in contrast to nondisease genes
that become connected to more genes with age (i.e., PC 1
and degree correlate strongly and positively with gene age).
Importantly, we also showed that the distinct age distribu-
tions of disease genes could not account for the observed
networkproperties.Notethatthestrongpositivecorrelation
between gene age and degree for nondisease genes em-
phasizes the importance of studying PPI networks as evolv-
ing entities.
It is important to consider the possibility that disease
genes show distinct network properties because they are
better studied. We tested this possibility in several ways.
First, we did ﬁnd some evidence for the inspection bias in
that the disease genes were more often named than non-
disease genes and that the named genes had a higher de-
gree. Thereasonfor the observation thatnamed genes have
a higher degree is not clear given that it is both possible that
known genes are indeed better studied and thus have an
artiﬁcially high degree or that more highly connected genes
are mutable to more obvious phenotypes and thus become
detected in genetic studies moreoften and then named. Im-
portantly, our study is not affected by this possible bias be-
cause we can show that the observed patterns are still
detectable when we focus exclusively on only named genes
in both disease and nondisease sets. In addition, when we
subsamplednondiseasegenestothesamelevelofdegreeas
the disease genes, disease genes still showed signiﬁcantly
lower clustering coefﬁcients compared with nondisease
genes.
We found that genes that have been detected in GWAS
studies of disease but have not been previously identiﬁed as
disease genes (Mendelian or complex disease) deviate very
slightlyfromnondiseasegenes intheir networkpropertiesin
the direction of other disease genes. The weakness of this
signal is intriguing. First and foremost this might be due to
the small sample size of GWAS genes. This can explain some
but not all the weakness of the signal because GWAS genes
do have signiﬁcantly weaker signal than complex disease
genes. If the weakness of the signal is not a mere question
of statistical powerone can think of a number of reasons for
this pattern. First, it is possible that GWAS genes relate to
a distinct set of diseases that show distinct etiology and that
the genes that underlie these diseases behave in a distinct
manner. Second, it is possible that GWAS genes are related
to more polygenic diseases on average. However, this sec-
ond possibility does not seem very likely as the complex dis-
ease genes show the most strikingly different network
patterns that are even stronger than those of Mendelian
genes. The third possibility is that the identiﬁcation of genes
associated with speciﬁc GWAS-identiﬁed SNPs has some er-
ror. This does seem likely especially given that regulatory re-
gions in the human genome are often located many tens or
even hundreds of base pairs away from the coding regions
they affect (Wellcome Trust Case Control Consortium 2007;
Eeles et al. 2008; Loos et al. 2008; Zeggini et al. 2008) and it
isnotthemoststraightforwardtasktopredictwhichgene(s)
are associated with an identiﬁed intergenic polymorphism.
In the future, disease prioritization studies such as this could
help us predict which genes located in the neighborhood of
GWAS-associated SNPs are directly and causally associated
with the studied diseases.
Taken together, we demonstrate that Mendelian and
complex disease genes have distinct and consistent proper-
ties in the PPI network. Disease genes occupy topologically
critical positions of the network as brokersthat interact with
many neighboring proteins that are less connected them-
selves. It will be important to study whether such broker
genes indeed specify particularly fragile points in the net-
work. Finally,ourresults providenew insights fordeveloping
powerful and discriminating approaches for prioritizing and
identifying causal genes related to human disease.
Supplementary Material
Supplementary ﬁgs. S1–S8 and table S1 are available at
Genome Biology and Evolution online (http://www.
oxfordjournals.org/our_journals/gbe/).
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